Cited by 372Global Cancer Incidence and ScreeningEconomic and Financial Impacts of CancerAdvances in Oncology and Radiotherapy

Cancer survival: global surveillance will stimulate health policy and improve equity

Coleman, Michel P·2014·The Lancet

Abstract

Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(13)62225-4

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Coleman, M. P.
Affiliations
Cancer Research UK (GB)
Corresponding author
Coleman, Michel P
Venue
The Lancet
Publisher
Elsevier BV
Published
2014-02
Volume
383
Issue
9916
Pages
564-573
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2057721627
Cited by
370
References
72
Citations by year
2026: 13 · 2025: 12 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 13 · 2020: 222 · 2019: 14 · 2018: 18 · 2017: 16 · 2016: 16 · 2015: 9 · 2014: 7 · 2013: 1
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
Cancer Research UK (11700, 16148)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
Keywords
cancer survival, health equity, health policy, access to cancer care, health system effectiveness, cancer epidemiology
MeSH terms
Adult, Aged, Health Planning, Health Policy, Health Services Accessibility, Humans, International Cooperation, Middle Aged, Neoplasms, Global Health, Survival Analysis, Cost of Illness, Healthcare Disparities, Mortality, Premature, Public Health Surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review